|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2964258 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14761062.0 |
| Date of filing the European patent application | 2014-03-04 | |
| (97) | Date of publication of the European application | 2016-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation | 2020-10-12 |
| (86) | Number | PCT/US2014/020064 |
| Date | 2014-03-04 |
| (87) | Number | WO 2014/137962 |
| Date | 2014-09-12 |
| (30) | Number | Date | Country code |
| 201361774732 P | 2013-03-08 | US |
| (72) |
BEIDLER, Catherine Brautigam, US
BRIGHT, Stuart Willis, US
GIRARD, Daniel Scott, US
KIKLY, Kristine Kay, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Antikūnai, kurie jungiasi prie IL-23 |
| ANTIBODIES THAT BIND IL-23 |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 12 | 289.00 EUR |
| 2026-03-04 |